Galetin A[au] - Search Results

Year	Number of Results
1998	1
2002	1
2003	3
2004	2
2005	5
2006	3
2007	4
2008	10
2009	3
2010	4
2011	8
2012	9
2013	8
2014	11
2015	7
2016	6
2017	12
2018	15
2019	7
2020	8
2021	11
2022	6
2023	1

1

The International Transporter Consortium: Summarizing Advances in the Role of Transporters in Drug Development.

Giacomini KM, Galetin A, Huang SM. Giacomini KM, et al. Among authors: galetin a. Clin Pharmacol Ther. 2018 Nov;104(5):766-771. doi: 10.1002/cpt.1224. Clin Pharmacol Ther. 2018. PMID: 30137696 No abstract available.

2

Application of a gut-liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil.

Milani N, Parrott N, Ortiz Franyuti D, Godoy P, Galetin A, Gertz M, Fowler S. Milani N, et al. Among authors: galetin a. Lab Chip. 2022 Jul 26;22(15):2853-2868. doi: 10.1039/d2lc00276k. Lab Chip. 2022. PMID: 35833849

3

Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies.

Docci L, Milani N, Ramp T, Romeo AA, Godoy P, Franyuti DO, Krähenbühl S, Gertz M, Galetin A, Parrott N, Fowler S. Docci L, et al. Among authors: galetin a. Lab Chip. 2022 Mar 15;22(6):1187-1205. doi: 10.1039/d1lc01161h. Lab Chip. 2022. PMID: 35107462

4

PBPK models for the prediction of in vivo performance of oral dosage forms.

Kostewicz ES, Aarons L, Bergstrand M, Bolger MB, Galetin A, Hatley O, Jamei M, Lloyd R, Pepin X, Rostami-Hodjegan A, Sjögren E, Tannergren C, Turner DB, Wagner C, Weitschies W, Dressman J. Kostewicz ES, et al. Among authors: galetin a. Eur J Pharm Sci. 2014 Jun 16;57:300-21. doi: 10.1016/j.ejps.2013.09.008. Epub 2013 Sep 21. Eur J Pharm Sci. 2014. PMID: 24060672 Review.

5

Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction.

Galetin A, Zhao P, Huang SM. Galetin A, et al. J Pharm Sci. 2017 Sep;106(9):2204-2208. doi: 10.1016/j.xphs.2017.03.036. Epub 2017 Apr 5. J Pharm Sci. 2017. PMID: 28390843 Review.

6

Quantifying gut wall metabolism: methodology matters.

Hatley OJ, Jones CR, Galetin A, Rostami-Hodjegan A. Hatley OJ, et al. Among authors: galetin a. Biopharm Drug Dispos. 2017 Mar;38(2):155-160. doi: 10.1002/bdd.2062. Epub 2017 Feb 14. Biopharm Drug Dispos. 2017. PMID: 28039878 Free PMC article. No abstract available.

7

Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation Method.

Lang J, Vincent L, Chenel M, Ogungbenro K, Galetin A. Lang J, et al. Among authors: galetin a. AAPS J. 2020 Oct 8;22(6):129. doi: 10.1208/s12248-020-00502-8. AAPS J. 2020. PMID: 33033962 Clinical Trial.

8

In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods.

Yoshida K, Zhao P, Zhang L, Abernethy DR, Rekić D, Reynolds KS, Galetin A, Huang SM. Yoshida K, et al. Among authors: galetin a. J Pharm Sci. 2017 Sep;106(9):2209-2213. doi: 10.1016/j.xphs.2017.04.045. Epub 2017 Apr 26. J Pharm Sci. 2017. PMID: 28456729 Review.

9

Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver.

Chu X, Korzekwa K, Elsby R, Fenner K, Galetin A, Lai Y, Matsson P, Moss A, Nagar S, Rosania GR, Bai JP, Polli JW, Sugiyama Y, Brouwer KL; International Transporter Consortium. Chu X, et al. Among authors: galetin a. Clin Pharmacol Ther. 2013 Jul;94(1):126-41. doi: 10.1038/clpt.2013.78. Epub 2013 Apr 10. Clin Pharmacol Ther. 2013. PMID: 23588320 Free PMC article. Review.

10

Intestinal first-pass metabolism: bridging the gap between in vitro and in vivo.

Galetin A. Galetin A. Curr Drug Metab. 2007 Oct;8(7):643-4. doi: 10.2174/138920007782109779. Curr Drug Metab. 2007. PMID: 17979662 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results